Progenerative Medical Inc.
progenerative.com
Health Care
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Overview
What We Do Progenerative Medical is translating clinically-proven reduced pressure technology into medical treatments for orthopedic surgeries. Who We Are The Company founders have extensive experience in medical device innovation, product development, clinical evaluation, and commercialization.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Alamo AngelsVia a fund
41 portfolio companies: Merit Medical Systems, Robot Creative, Texas Research and Technology Foundation and 38 more
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Regenn NPTS Clinical Safety Study Completes Patient Enrollment
Progenerative Medical is pleased to announce the enrollment completion of the clinical safety study for its Regenn Negative Pressure Therapy System (NPTS). CEO, Neal Vail, said, "This is a major milestone for us, putting us on track to complete the study
Read more
Report
Douglas Burton, MD, joins Progenerative as Chief Medical Officer
PGM is pleased to announce the addition of Dr. Douglas Burton to the Progenerative team. Dr. Burton is a respected spine surgeon with over 25 years of experience in adult and pediatric spine surgery. Dr. Burton previously led PGM's Medical Advisory Board
Read more
Report
Regenn NPTS Clinical Safety Study Achieves Enrollment Milestone
PGM is pleased to announce the enrollment of the twentieth patient in its IDE-approved clinical safety study for its Regenn Negative Pressure Therapy System (NPTS). "We are pleased with our clinical experience of the Regenn NPTS and continue to work with
Read more
Report
Progenerative Initiates Clinical Safety Trial for Regenn NPTS
PGM is pleased to announce the completion of the first patient in its IDE-approved clinical safety study for its Regenn Negative Pressure Therapy System. "Placing the first Regenn NPTS device was an honor and I look forward to continuing to work with the
Read more
Report
Progenerative Medical signs Research Collaboration Agreement with Johnson & Johnson Medical Devices Companies Center for Device Innovation at the Texas Medical Center
Progenerative Medical (PGM) and Johnson & Johnson Medical Devices Companies Center for Device Innovation at Texas Medical Center (CDI @ TMC) have agreed to explore new orthopedic applications based on PGM's extensive intellectual property portfolio for re
Read more
Report
Progenerative Joins TMCx Accelerator Program
PGM is pleased to be one of seven companies selected to join the 2021 TMCx accelerator program. Working with TMCx will provide PGM with opportunities to build sustainable relationships with the world class members of TMC Innovation community as we receive
Read more
Report
Progenerative Joins Capital Factory Accelerator
Progenerative Medical has been accepted into the November 2020 cohort of companies that will participate in their accelerator program. The Capital Factory (CF) accepts a limited number of companies into their program; a strong testimonial to their belief
Read more
Report
Progenerative Participates in TMCx Bootcamp
Progenerative Medical Inc (PGM) is participating in the virtual Texas Medical Center Bootcamp (TMCx), the first step in the selection process for becoming a part of the next cohort of TMCx resident companies. It's an honor to have been chosen. This gives
Read more
Report
Kien Nguyen Joins Progenerative as Chief Commercialization Officer
PGM is pleased to announce the addition of Kien Nguyen to the Progenerative team. Kien played a key role in the early concept development of Regenn Therapy while at Kinetic Concepts, Inc., and brings valuable technology and market experience to the PGM te
Read more
Report
Show more news